Hrd1 facilitates tau degradation by proteasome and lysosome pathways

来源 :The 12th Meeting of the Asia Pacific Federation of Pharmacol | 被引量 : 0次 | 上传用户:xxxx000456
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Intraneuronal accumulation of abnormal phosphorylated tau (p-tau) is a molecular pathology in many neurodegenerative tauopathies, including Alzheimers disease (AD), Progressive supranuclear palsy and frontotemporal dementia with parkinsonism-linked to chromosome 17 (FTDP-17).
其他文献
Aim: Our previous study has demonstrated that xanthotoxol possesses neuroprotective properties following transient focal cerebral ischemia.The present study was designed to investigate the effect of x
Aim: The present study is to investigate the effect and mechanisms of xanthoceraside on memory impairments and central cholinergic system in Alzheimers disease (AD) rat model conducted by lesions of b
Aim: To study the quantification methods and pharmacokinetic application of lapachol.Methods: A sensitive and specific high-performance liquid chromatography-tandem mass spectrometry method (LC/ESI/MS
Aim: The activity of nuclear factor (NF-κB) is modulated by cytoplasmic repressor activator protein 1 (Rap1) in cancel cells.Experiments were designed to test whether or not Rap1 is present in atherom
Aim: The study is to investigate whether diuretic acetazolamide (AZA) protects against renal ischemia-reperfusion (I/R) injury, and its possible link with water channel aquaporin-1 (AQP1).Methods: In
Aim: The present study investigated the effects of WS070117, a novel small molecule compound, on foam cell formation, and the possible underlying mechanism.Methods: J774.A1 murine macrophages were pre
Aim: Experiments were designed to determine the effects of thymoquinone, an alkaloid with vasodilator properties, in coronary arteries.Methods: Rings, with or without endothelium, of porcine coronary
Aim: To investigate whether 4-hydroxynonenal (4-HNE) regulates asymmetric dimethylarginine (ADMA) metabolism through affecting the expression of ADMA metabolizing enzymes and the involvement of microR
Aim: An in vitro study has shown joint-protective effects of ginsenoside metabolite compound K (CK) in RA, but the effects of CK in RA animal model and the mechanisms are still unknown.In this study,
Aim: Blood brain barrier (BBB) dysfunction is a common facet of cerebral ischemia, and the alteration of drug transporter, P-glycoprotein (P-gp), has been documented.This study explores influence of d